miRNA profiles in cerebrospinal fluid from patients with central hypersomnias

Anja Holm; Claus Heiner Bang-Berthelsen; Stine Knudsen; Signe Modvig; Birgitte Rahbek Kornum; Steen Gammeltoft; Poul J Jennum

doi:10.1016/j.jns.2014.09.047

miRNA profiles in cerebrospinal fluid from patients with central hypersomnias

Anja Holm, Claus Heiner Bang-Berthelsen, Stine Knudsen, Signe Modvig, Birgitte Rahbek Kornum, Steen Gammeltoft, Poul J Jennum

Section of General Practice

8 Citations (Scopus)

Abstract

MicroRNAs (miRNAs) are involved in the pathogenesis of many human diseases, including some neurological disorders. Recently, we have reported dysregulated miRNAs in plasma from patients with central hypersomnias including type 1 and type 2 narcolepsy, and idiopathic hypersomnia. This study addressed whether miRNA levels are altered in the cerebrospinal fluid (CSF) of patients with central hypersomnias. We conducted high-throughput analyses of miRNAs in CSF from patients using quantitative real-time polymerase chain reaction panels. We identified 13, 9, and 11 miRNAs with a more than two-fold change in concentration in CSF from patients with type 1 and type 2 narcolepsy and idiopathic hypersomnia, respectively, compared with matched healthy controls. Most miRNAs differed in more than one of the sleep disorders. However, all miRNAs were detected at low levels in CSF and varied between individuals. None of them showed significant differences in concentrations between groups after correcting for multiple testing, and none could be validated in an independent cohort. Nevertheless, approximately 60% of the most abundant miRNAs in the profile reported here have previously been identified in the CSF of healthy individuals, showing consistency with previous miRNA profiles found in CSF. In conclusion, we were not able to demonstrate distinct levels or patterns of miRNAs in CSF from central hypersomnia patients.

Original language	English
Journal	Journal of the Neurological Sciences
Volume	347
Issue number	1-2
Pages (from-to)	199-204
Number of pages	6
ISSN	0022-510X
DOIs	https://doi.org/10.1016/j.jns.2014.09.047
Publication status	Published - 15 Dec 2014

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.1016/j.jns.2014.09.047

Cite this

@article{bb4f7c2a59424ba18bc1a17de24f5aa6,

title = "miRNA profiles in cerebrospinal fluid from patients with central hypersomnias",

abstract = "MicroRNAs (miRNAs) are involved in the pathogenesis of many human diseases, including some neurological disorders. Recently, we have reported dysregulated miRNAs in plasma from patients with central hypersomnias including type 1 and type 2 narcolepsy, and idiopathic hypersomnia. This study addressed whether miRNA levels are altered in the cerebrospinal fluid (CSF) of patients with central hypersomnias. We conducted high-throughput analyses of miRNAs in CSF from patients using quantitative real-time polymerase chain reaction panels. We identified 13, 9, and 11 miRNAs with a more than two-fold change in concentration in CSF from patients with type 1 and type 2 narcolepsy and idiopathic hypersomnia, respectively, compared with matched healthy controls. Most miRNAs differed in more than one of the sleep disorders. However, all miRNAs were detected at low levels in CSF and varied between individuals. None of them showed significant differences in concentrations between groups after correcting for multiple testing, and none could be validated in an independent cohort. Nevertheless, approximately 60% of the most abundant miRNAs in the profile reported here have previously been identified in the CSF of healthy individuals, showing consistency with previous miRNA profiles found in CSF. In conclusion, we were not able to demonstrate distinct levels or patterns of miRNAs in CSF from central hypersomnia patients.",

author = "Anja Holm and Bang-Berthelsen, {Claus Heiner} and Stine Knudsen and Signe Modvig and Kornum, {Birgitte Rahbek} and Steen Gammeltoft and Jennum, {Poul J}",

year = "2014",

month = dec,

day = "15",

doi = "10.1016/j.jns.2014.09.047",

language = "English",

volume = "347",

pages = "199--204",

journal = "Journal of the Neurological Sciences",

issn = "0022-510X",

publisher = "Elsevier",

number = "1-2",

}

TY - JOUR

T1 - miRNA profiles in cerebrospinal fluid from patients with central hypersomnias

AU - Holm, Anja

AU - Bang-Berthelsen, Claus Heiner

AU - Knudsen, Stine

AU - Modvig, Signe

AU - Kornum, Birgitte Rahbek

AU - Gammeltoft, Steen

AU - Jennum, Poul J

PY - 2014/12/15

Y1 - 2014/12/15

N2 - MicroRNAs (miRNAs) are involved in the pathogenesis of many human diseases, including some neurological disorders. Recently, we have reported dysregulated miRNAs in plasma from patients with central hypersomnias including type 1 and type 2 narcolepsy, and idiopathic hypersomnia. This study addressed whether miRNA levels are altered in the cerebrospinal fluid (CSF) of patients with central hypersomnias. We conducted high-throughput analyses of miRNAs in CSF from patients using quantitative real-time polymerase chain reaction panels. We identified 13, 9, and 11 miRNAs with a more than two-fold change in concentration in CSF from patients with type 1 and type 2 narcolepsy and idiopathic hypersomnia, respectively, compared with matched healthy controls. Most miRNAs differed in more than one of the sleep disorders. However, all miRNAs were detected at low levels in CSF and varied between individuals. None of them showed significant differences in concentrations between groups after correcting for multiple testing, and none could be validated in an independent cohort. Nevertheless, approximately 60% of the most abundant miRNAs in the profile reported here have previously been identified in the CSF of healthy individuals, showing consistency with previous miRNA profiles found in CSF. In conclusion, we were not able to demonstrate distinct levels or patterns of miRNAs in CSF from central hypersomnia patients.

AB - MicroRNAs (miRNAs) are involved in the pathogenesis of many human diseases, including some neurological disorders. Recently, we have reported dysregulated miRNAs in plasma from patients with central hypersomnias including type 1 and type 2 narcolepsy, and idiopathic hypersomnia. This study addressed whether miRNA levels are altered in the cerebrospinal fluid (CSF) of patients with central hypersomnias. We conducted high-throughput analyses of miRNAs in CSF from patients using quantitative real-time polymerase chain reaction panels. We identified 13, 9, and 11 miRNAs with a more than two-fold change in concentration in CSF from patients with type 1 and type 2 narcolepsy and idiopathic hypersomnia, respectively, compared with matched healthy controls. Most miRNAs differed in more than one of the sleep disorders. However, all miRNAs were detected at low levels in CSF and varied between individuals. None of them showed significant differences in concentrations between groups after correcting for multiple testing, and none could be validated in an independent cohort. Nevertheless, approximately 60% of the most abundant miRNAs in the profile reported here have previously been identified in the CSF of healthy individuals, showing consistency with previous miRNA profiles found in CSF. In conclusion, we were not able to demonstrate distinct levels or patterns of miRNAs in CSF from central hypersomnia patients.

U2 - 10.1016/j.jns.2014.09.047

DO - 10.1016/j.jns.2014.09.047

M3 - Journal article

C2 - 25451005

SN - 0022-510X

VL - 347

SP - 199

EP - 204

JO - Journal of the Neurological Sciences

JF - Journal of the Neurological Sciences

IS - 1-2

ER -

miRNA profiles in cerebrospinal fluid from patients with central hypersomnias

Abstract

UN SDGs

Access to Document

Fingerprint

Cite this